800 drugs in development

The incidence and mortality of cancers continue to increase in China. According to estimates, the new cancer cases in China reached 4.29 million cases in 2015, accounting for 20% of the world’s new cases, with 2.81 million death cases.
The highest-incidence cancers for males and females in China were separately lung cancer and breast cancer, different from the developed countries. The highest-incidence cancers for males and females in developed countries were separately prostatic cancer and breast cancer, according to 2012 data of GLOBOCAN.
Cancer prevention and treatment are great challenges confronted with by all humans. The reduction of cancer incidence and mortality and extension of patients’ survival time are important subjects for Chinese and global pharmaceutical industries.
The latest report of Pharmaceutical Research and Manufacturers of America shows that there are more than 800 cancer drugs in development, wherein, 73% drugs have the potential to become "personalized drugs".
Read More










(All Rights Reserved)